NeoStem

NeoStem

Biopharmaceutical company developing cellular therapies for the oncology, immunology, and regenerative medicine sectors.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round

$38.0m

Post IPO Equity
Total Funding000k
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by NeoStem

Edit
PCT Cell Therapy Services
ACQUISITION by NeoStem Jan 2011